Once Retatrutide gets an approval, it can be a great addition as a peptide therapy for weight loss
The law (Medicare Modernization Act of 2003) explicitly excludes drugs when used for weight loss, weight gain, or anorexia. (ASPE) Some proposed changes (including reinterpreting the exclusion for obesity) were considered , but in April 2025 those were not finalized
In addition, labelled semaglutide can also cross the blood brain barrier to the caudal lateral septal nucleus (LSc), septofimbrial nucleus (SF), arcuate nucleus (ARC), median preoptic nucleus (MnPO), dorsal vagal complex (DVC)
The glucagon receptor component increases energy expenditure and fat oxidation
If migraines persist despite lifestyle optimization, several clinical approaches may help